Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Dow Inc has an analyst consensus of Hold, with a price target consensus of $32.13, which is a 12.90% upside from current levels. In a report released on June 30, Mizuho Securities also maintained a ...